The veterinary and pharmaceutical laboratory receives the approval of BME and now wants to attract 17 million euros from qualified investors and eight million from all kinds of investors.
Labiana Health faces the final stretch for its stock market debut, scheduled for the middle of this month. The veterinary and pharmaceutical group announced yesterday that it already has the authorization of the Spanish Stock Exchanges and Markets (BME) and explained that the next day 13 t